{"id":3093,"date":"2020-03-04T16:34:00","date_gmt":"2020-03-04T16:34:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=3093"},"modified":"2025-01-14T22:14:23","modified_gmt":"2025-01-14T22:14:23","slug":"modelling-nafld-disease-burden-in-four-asian-regions-2019-2030","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/modelling-nafld-disease-burden-in-four-asian-regions-2019-2030\/","title":{"rendered":"Mod\u00e9lisation de la charge de morbidit\u00e9 de la NAFLD dans quatre r\u00e9gions d'Asie-2019-2030"},"content":{"rendered":"

R\u00e9sum\u00e9<\/h2>\n\n\n\n

Arri\u00e8re-plan<\/h3>\n\n\n\n

La st\u00e9atose h\u00e9patique non alcoolique (NAFLD) et la st\u00e9atoh\u00e9patite non alcoolique (NASH) repr\u00e9sentent une proportion croissante de maladies h\u00e9patiques dans la r\u00e9gion Asie-Pacifique. De nombreuses r\u00e9gions de la r\u00e9gion connaissent des \u00e9pid\u00e9mies de syndrome m\u00e9tabolique parmi les populations vieillissantes rapidement.<\/p>\n\n\n\n

Buts<\/h3>\n\n\n\n

Estimer en mod\u00e9lisant la croissance des populations de NAFLD, y compris les cas de fibrose importante qui sont les plus susceptibles de souffrir d'une maladie h\u00e9patique avanc\u00e9e et de la mortalit\u00e9 associ\u00e9e.<\/p>\n\n\n\n

M\u00e9thodes<\/h3>\n\n\n\n

Un mod\u00e8le de progression de la maladie a \u00e9t\u00e9 utilis\u00e9 pour r\u00e9sumer et projeter la progression de la fibrose parmi les populations NAFLD de Hong Kong, Singapour, Cor\u00e9e du Sud et Taiwan. Pour chaque domaine, les changements dans la pr\u00e9valence de l'ob\u00e9sit\u00e9 chez les adultes ont \u00e9t\u00e9 utilis\u00e9s pour extrapoler les tendances \u00e0 long terme de l'incidence de la NAFLD.<\/p>\n\n\n\n

R\u00e9sultats<\/h3>\n\n\n\n

Dans les zones \u00e9tudi\u00e9es, les cas de NAFLD pr\u00e9valents devraient augmenter de 6%-20% entre 2019 et 2030, tandis que les cas de NASH pr\u00e9valents augmenteraient de 20%-35%. Les cas incidents de carcinome h\u00e9patocellulaire devraient augmenter de 65%-85%, tandis que les cas incidents de cirrhose d\u00e9compens\u00e9e augmenteront de 65%-100% d'ici 2030. De m\u00eame, la mortalit\u00e9 li\u00e9e \u00e0 la NAFLD devrait augmenter entre 65% et 100% de 2019 \u00e0 2030. augmenter parall\u00e8lement aux tendances \u00e0 la hausse du syndrome m\u00e9tabolique et de l'ob\u00e9sit\u00e9 parmi les populations de la r\u00e9gion. Cela conduit \u00e0 plus de cas de maladie h\u00e9patique avanc\u00e9e et de mortalit\u00e9 associ\u00e9e.<\/p>\n\n\n\n

Conclusions<\/h3>\n\n\n\n

La pr\u00e9vention de la croissance des populations diab\u00e9tiques et ob\u00e8ses sera un facteur cl\u00e9 pour r\u00e9duire l'augmentation continue de la charge de morbidit\u00e9 li\u00e9e \u00e0 la NAFLD dans la r\u00e9gion Asie-Pacifique.<\/p>\n\n\n\n

Des pays:<\/strong> Hong Kong, Singapour, Cor\u00e9e du Sud, Ta\u00efwan<\/p>\n\n\n\n

\n
Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Summary Background Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) account for an increasing proportion of liver disease in the Asia-Pacific region. Many areas in the region are experiencing epidemics of metabolic syndrome among rapidly ageing populations. Aims To estimate using modelling the growth in NAFLD populations, including cases with significant fibrosis that are […]<\/p>\n","protected":false},"author":24,"featured_media":3187,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[12,24],"publication-author":[683,684,681,535,685,688,690,687,686,691,682,689,694,494,664,692,693,506],"class_list":["post-3093","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-modelling","tag-nafld","publication-author-chan-hly","publication-author-chien-rn","publication-author-chuang-wl","publication-author-estes-c","publication-author-fung-j","publication-author-goh-gb","publication-author-hu-th","publication-author-huang-jf","publication-author-jang-bk","publication-author-jun-dw","publication-author-kao-jh","publication-author-lee-jw","publication-author-lin-hc","publication-author-razavi-h","publication-author-razavi-shearer-k","publication-author-seto-wk","publication-author-wong-gl","publication-author-wong-vw"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=3093"}],"version-history":[{"count":5,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3093\/revisions"}],"predecessor-version":[{"id":7481,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3093\/revisions\/7481"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3187"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=3093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=3093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=3093"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=3093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}